Skip to main content
. 2021 Jul 5;2021(7):CD011301. doi: 10.1002/14651858.CD011301.pub2

Comparison 63. NewBontA (Prosigne®) 20 units versus OnabotulinumtoxinA 20 units one treatment in glabellar lines.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
63.1 Physician assessment of success by analysing scores and scales 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
63.1.1 12 weeks 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected